Efficacy and safety of fenofibrate add-on therapy in patients with primary biliary cholangitis refractory to ursodeoxycholic acid: A retrospective study and updated meta-analysis

Background: Ursodeoxycholic acid (UDCA) is currently used for the treatment of primary biliary cholangitis (PBC), but some people do not respond well to UDCA. It reported that the combination of fenofibrate and UDCA can improve the clinical indices in these patients. However, more high-quality evide...

Descripción completa

Detalles Bibliográficos
Autores principales: Guoyun, Xuan, Dawei, Ding, Ning, Liu, Yinan, Hu, Fangfang, Yang, Siyuan, Tian, Hao, Sun, Jiaqi, Yang, Ang, Xu, Guanya, Guo, Xi, Chen, Yulong, Shang, Ying, Han
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Pharmacology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9468667/
https://www.ncbi.nlm.nih.gov/pubmed/36110537
http://dx.doi.org/10.3389/fphar.2022.948362

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9468667/
https://www.ncbi.nlm.nih.gov/pubmed/36110537
http://dx.doi.org/10.3389/fphar.2022.948362

Ejemplares similares